Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

Share Price is delayed by 15 minutes
Get Live Data
185.00    -1.80 (-0.96%)
Bid:
184.40
Ask:
185.00
Spread: 0.60 (0.325%)
Market Cap: £1.86b
BME Live PriceLast checked at - London Stock Exchange

Intraday B&M Share Chart

Pre Stabilisation Notice

1 Jul 2020 11:07

RNS Number : 7204R
HSBC Bank plc
01 July 2020
 

1st July 2020

 

B&M EUROPEAN VALUE RETAIL S.A. 

Pre Stabilisation Notice

HSBC (contact: 'synd manager'; telephone: +44 207 992 8066) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

B&M EUROPEAN VALUE RETAIL S.A.

Guarantor (if any):

na

Aggregate nominal amount:

GBP 350,000,000

Description:

Fixed 2025NC2

Offer price:

TBC /

Other offer terms:

 

Stabilisation:

Stabilising Manager(s):

BNP Paribas, HSBC, Barclays, BoFA, Commerzbank, Goldman Sachs, Lloyds

Stabilisation period expected to start on:

3rd July 2020

Stabilisation period expected to end no later than:

12th August 2020

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

 In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC, as amended (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STAGZGGNGMDGGZM
Date   Source Headline
19th Nov 20244:52 pmRNSPricing of £250 Million Senior Secured Notes
18th Nov 20248:00 amRNSLaunch of £250 million Senior Secured Notes Offer
14th Nov 20247:00 amRNSFY25 Interim Results
31st Oct 20241:00 pmRNSTiming of Announcement of Interim Results
17th Oct 20243:00 pmRNSTR1: Notification of Major Holding in Company
4th Oct 20245:30 pmRNSDirector Declaration
30th Sep 20242:15 pmRNSTotal Voting Rights
13th Sep 20242:51 pmRNSGrant of Share Options to French Senior Management
12th Sep 20244:31 pmRNSPDMR Exercise of Share Options
3rd Sep 20242:15 pmRNSAppointment To Remuneration Committee
2nd Sep 20245:00 pmRNSTotal Voting Rights
29th Aug 20242:45 pmRNSPDMR Shareholding notification
12th Aug 20245:30 pmRNSGrant of Share Options
31st Jul 20245:29 pmRNSTotal Voting Rights
25th Jul 20245:45 pmRNSGrant of Options to Directors
23rd Jul 20242:57 pmRNSEGM Voting results announcement
23rd Jul 20242:15 pmRNSAGM 2024 Voting results announcement
16th Jul 20244:56 pmRNSBlock listing six monthly return
16th Jul 20247:00 amRNSQ1 FY25 Trading Update
19th Jun 20247:00 amRNSNotice of AGM and EGM
17th Jun 202410:00 amRNSGrant of Share Options
13th Jun 20244:50 pmRNSNotice of FY25 Q1 Trading Statement
7th Jun 20243:25 pmRNSPDMR Purchase of Shares
5th Jun 20247:05 amRNSAppointment of new Chair
5th Jun 20247:00 amRNSFY24 Preliminary Results
29th May 20242:30 pmRNSDirector Appointment & Results of OGM
24th Apr 20249:00 amRNSNotice of Ordinary General Meeting
16th Apr 20247:00 amRNSFY24 Post Close Trading Statement
4th Apr 202410:00 amRNSNotice of FY24 Post Close Trading Statement
22nd Mar 20249:00 amRNSBoard Appointment
8th Feb 20249:00 amRNSConfirmation of timing of FY24 Preliminary Results
1st Feb 20241:00 pmRNSMajor Shareholding in Company TR-1
30th Jan 20246:23 pmRNSHolding(s) in Company
24th Jan 202410:00 amRNSPDMR Purchase of Shares
23rd Jan 202412:00 pmRNSB&M Plans Chairman Succession
18th Jan 20242:46 pmRNSNotification of Major Shareholding
15th Jan 20242:20 pmRNSBlock listing Interim Review
9th Jan 20247:00 amRNSGolden Quarter - strong profitable growth
22nd Dec 202312:00 pmRNSCorrection: PDMR announcement
22nd Dec 20238:30 amRNSPost Stabilisation Notice
19th Dec 20239:04 amRNSPCA Notification
15th Dec 20239:00 amRNSNotification of major holdings
13th Dec 202312:10 pmRNSAnnouncement further to recent placing by SSA
30th Nov 20235:41 pmRNSChange of Registered Office
30th Nov 20234:01 pmRNSTotal Voting Rights
28th Nov 20239:22 amRNSDirector/PDMR Shareholding
27th Nov 20235:13 pmRNSNotice of FY24 Third Quarter Trading Statement
24th Nov 202310:35 amRNSPDMR Notification
21st Nov 202311:32 amRNSFinal Results of Tender Offer 3.625% Senior Notes
15th Nov 202310:11 amRNSTender Offer Indicative Maximum Acceptance Amount

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.